Su325 HEPATIC STEATOSIS MAY LEAD TO WORSE OUTCOMES IN PATIENTS WITH LIVER INJURY AND COVID-19

Danial H. Shaikh,Haozhe Sun,Harish Patel,Dongmin Shin,Ahmed Baiomi,Shehriyar Mehershahi,Madhavi Ravi,Jasbir Makker,Bhavna Balar,Suresh Kumar Nayudu

DOI: https://doi.org/10.1016/s0016-5085(21)02761-x

IF: 29.4

2021-01-01

Gastroenterology

Abstract:Patients & Methods This study retrospectively identified 5 pregnant females with Covid-19 infection who had liver injury between 7/9/20 and 9/18/20.Aims The aim of this study was to describe the clinical characteristics of five pregnant patients with elevated liver enzymes and COVID-19. ResultsWe identified 5 pregnant patients with Covid-19 who had elevated liver enzymes.None of the patients had pre-existing liver disease.On admission, one patient had significantly elevated liver enzymes (AST and ALT), two had mildly elevated enzymes and two had enzymes within normal limits.AST and ALT rose during admission from anywhere between two to twenty five times the admission values.Alkaline phosphatase on admission was normal, and remained stable in all five patients.All patients showed normal synthetic and excretory functions, they had normal prothrombin time and bilirubin levels during the hospital stay.Of the five patients, the decision to deliver was made in one patient at 33 weeks gestational age in which ultrasound showed concern for intrauterine growth restriction and borderline oligohydramnios.These ultrasound findings, in addition to worsening liver enzymes, prompted the decision for delivery due to inability to exclude preeclampsia with severe features.The other 4 patients were discharged to continue pregnancy.All 5 patients were discharged in stable condition.Conclusions This case series comprised 5 pregnant patients with COVID-19 and elevated liver enzymes.The pattern of liver test abnormality in all cases was hepatocellular, which is consistent with other studies of COVID-19 related liver injury 7 .Several etiologies of elevated transaminases should be considered in the evaluation of pregnant females with COVID-19, particularly to exclude pregnancy-specific conditions that may necessitate prompt or early delivery.As this pandemic continues, COVID-19 may be added to the differential diagnosis of pregnant patients with elevated liver enzymes. Su324